Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for Transplantation-Associated Thrombotic Microangiopathy
NCT07279610Phase 3Active, not recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- May 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in thrombotic microangiopathy (TMA), sponsored by First Affiliated Hospital of Soochow University. Started May 2024; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
thrombotic microangiopathy (TMA)
Beyond the preview
Go deeper on NCT07279610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07279610.